Additionally, we determined the levels of anti-Spike RBD antibodies in sera from 16 convalescent COVID-19 patients at 150 days after recovery collected from Beijing You An Hospital and found that their anti-Spike RBD antibody levels were similar to those detected in the sera of vaccinated subjects collected within 120 days of vaccination (Fig. 1B), but statistically significantly higher than those collected more than 120 days post-vaccination (Fig. 1C). The gene discussed is CHMP5; the disease is COVID-19.